Delivering on the promise of precision cancer medicine and why it matters even more during a pandemic

MedCity News July 30, 2020
Dan Rhodes

While many of us have avoided exposure to Covid-19 by sheltering in place, patients with […]

While many of us have avoided exposure to Covid-19 by sheltering in place, patients with advanced cancer have faced difficult choices about moving ahead with immune-compromising, but potentially life-saving treatments, and leaving the safety of their homes to receive infusions at hospitals or treatment centers.

Even more challenging, for many patients, the pandemic has altered the landscape of practically available treatment options. The best treatment for many patients with advanced cancer is often available only through a clinical trial. Trials traditionally have taken place at leading academic medical centers, which means patients often must travel long distances to participate and receive novel treatment.

Precision...

Today's Sponsors

Today's Sponsor